None listed
Conditions
Brief summary
This is a double blinded randomized trial of Botox injection for the treatment of complex anal fistulae. All patients will have a Seton drain placed at their initial surgery. After six weeks they will be randomized to either Botox injection to the anal sphincter or placebo as well as (in both groups) removal of the Seton drain. Patients will be followed up at 3,12 and 24 weeks to assess healing of the fistula.
Interventions
This is a blinded randomized trial of Botox injection with removal of the Seton drain and de- epithelialisation of the tract compared with Seton removal and de- epithelialisation alone for the treatment of complex anal fistulae. Dose of Botox: 2 X 40iU injections to the anal sphincters as a single administratio. This will be performed by the patient's treating surgeon. This procedure takes approximately thee minutes. Follow up will be done by a speicalist surgeon. The fistula will be judged to have healed (primary endpoint of the study) if the following criteria are met: • The external opening has healed. • The internal opening cannot be palpated on digital rectal examination. • The patient does not complain of any ongoing drainage from the fistula site.
Sponsors
Study design
Eligibility
Inclusion criteria
Complex anal fistula with Seton drain in situ
Exclusion criteria
• Patients with known Crohn’s disease of anorectal malignancy. • Patients with rectovaginal or anovaginal fistulae. • Patients with known generalised musculoskeletal disease. • Patients with known sensitivity to Botox. • Pregnant or breast- feeding women.